Early Dialysis Initiation Linked With Lower Death, MACE Risks
Whether the risk reductions justify early dialysis initiation is a matter of debate.
Whether the risk reductions justify early dialysis initiation is a matter of debate.
By the end of 2020, the cumulative incidence of COVID-19 diagnoses was 7.7% and 15.8% among individuals with CKD and those undergoing dialysis, respectively.
A sex-specific difference in dialysis initiation emerged in a study of participants in the multinational Chronic Kidney Disease Outcomes and Practice Patterns Study.
In 2020, nearly 72% of patients in a US study initiated dialysis at an eGFR of 10 mL/min/1.73 m2 or higher.
Daprodustat is as effective as erythropoiesis-stimulating agents in treating anemia in patients with dialysis-dependent and nondialysis-dependent chronic kidney disease.
Study finds no significant difference in hospitalization and death rates between patients who had a loop diuretic prescription at the time of peritoneal dialysis vs those who did not.
New study chronicles a growing proportion of patients using peritoneal dialysis and home hemodialysis since 2016.
Disparities largely persisted over time and were found in most ESRD Networks.
A recent meta-analysis demonstrated that patients on dialysis are less likely to produce an immune response than those not on dialysis.
During the initial height of the pandemic in 2020, the documented incidence of end-stage kidney disease, defined as initiation of maintenance dialysis or receipt of a preemptive kidney transplant, decreased compared with corresponding periods during 2017-2019.